These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32294495)

  • 1. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
    Li C; Cheng G
    Front Immunol; 2020; 11():1969. PubMed ID: 32849658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine for COVID-19: rationale, facts, hopes.
    Cortegiani A; Ippolito M; Ingoglia G; Einav S
    Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
    Vitte J; Michel M; Mezouar S; Diallo AB; Boumaza A; Mege JL; Desnues B
    Front Immunol; 2020; 11():2159. PubMed ID: 32983179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
    Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
    Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
    Keshtkar-Jahromi M; Bavari S
    Am J Trop Med Hyg; 2020 May; 102(5):932-933. PubMed ID: 32247318
    [No Abstract]   [Full Text] [Related]  

  • 9. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is hydroxychloroquine beneficial for COVID-19 patients?
    Li X; Wang Y; Agostinis P; Rabson A; Melino G; Carafoli E; Shi Y; Sun E
    Cell Death Dis; 2020 Jul; 11(7):512. PubMed ID: 32641681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.
    Mahalmani VM; Mahendru D; Sarma P; Prakash A; Medhi B
    Indian J Pharmacol; 2020; 52(2):75-78. PubMed ID: 32565593
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the role of rheumatologists in the era of COVID-19?
    Marotto D; Sarzi-Puttini P
    Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
    Funnell SGP; Dowling WE; Muñoz-Fontela C; Gsell PS; Ingber DE; Hamilton GA; Delang L; Rocha-Pereira J; Kaptein S; Dallmeier KH; Neyts J; Rosenke K; de Wit E; Feldmann H; Maisonnasse P; Le Grand R; Frieman MB; Coleman CM
    Nat Commun; 2020 Aug; 11(1):4253. PubMed ID: 32848158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
    Colunga Biancatelli RML; Berrill M; Catravas JD; Marik PE
    Front Immunol; 2020; 11():1451. PubMed ID: 32636851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment.
    Karlsen APH; Wiberg S; Laigaard J; Pedersen C; Rokamp KZ; Mathiesen O
    PLoS One; 2020; 15(8):e0237903. PubMed ID: 32817689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk.
    Offerhaus JA; Wilde AAM; Remme CA
    Heart Rhythm; 2020 Sep; 17(9):1480-1486. PubMed ID: 32622993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
    Zhao M
    Int J Antimicrob Agents; 2020 Jun; 55(6):105982. PubMed ID: 32305588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
    Sharma A; Kumar Sharma S; Shi Y; Bucci E; Carafoli E; Melino G; Bhattacherjee A; Das G
    Cell Death Dis; 2020 Jul; 11(7):516. PubMed ID: 32641762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.